A recessive screen for genes regulating hematopoietic stem cells

Blood

Volumn 116, Issue 26, 2010, Pages 5849-5858

  Papathanasiou, Peter ^a   Tunningley, Robert ^a   Pattabiraman, Diwakar R ^b   Ye, Ping ^b   Gonda, Thomas J ^b   Whittle, Belinda ^a   Hamilton, Adam E ^a   Cridland, Simon O ^c   Lourie, Rohan ^d   Perkins, Andrew C ^c,d  

^a Biology and Environment   (Australia)

^b Immunology and Metabolic Medicine   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d MATER ADULT HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN C MYB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; ERYTHROCYTE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE IDENTIFICATION; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENOTYPE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HIGH THROUGHPUT SCREENING; MALE; MOUSE; MYELOFIBROSIS; NONHUMAN; ONTOGENY; PEDIGREE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROGENY; PROTEIN INTERACTION; RECESSIVE GENE; REGULATORY MECHANISM; THROMBOCYTE; THROMBOCYTHEMIA;

EID: 78650656338     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-04-269951     Document Type: Article

References (47)

1. He S, Nakada D, Morrison SJ. Mechanisms of stem cell self-renewal. Annu Rev Cell Dev Biol. 2009;25:377-406.
2. Huber TL, Kouskoff V, Fehling HJ. Palis J. Keller G. Haemangioblast commitment is initiated in the primitive streak of the mouse embryo. Nature. 2004;432(7017):625-630.
3. Fraser ST, Isern J, Baron MH. Maturation and enucleation of primitive erythroblasts during mouse embryogenesis is accompanied by changes in cell-surface antigen expression. Blood. 2007;109(1):343-352.
4. Kingsley PD, Malik J, Fantauzzo KA. Palis J. Yolk sac-derived primitive erythroblasts enucleate during mammalian embryogenesis. Blood. 2004;104(1):19-25.
5. Tober J, Koniski A, McGrath KE, et al. The megakaryocyte lineage originates from hemangioblast precursors and is an integral component both of primitive and of definitive hematopoiesis. Blood. 2007;109(4):1433-1441.
6. Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell biology. Cell. 2008;132(4):631-644.
7. Weiss MJ, Orkin SH. GATA transcription factors: key regulators of hematopoiesis. Exp Hematol. 1995;23(2):99-107.
8. Mucenski ML, McLain K, Kier AB, et al. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell. 1991;65(4):677-689.
9. Porcher C, Swat W, Rockwell K. Fujiwara Y. Alt FW. Orkin SH. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell. 1996;86(1):47-57.
10. Tsai FY, Keller G, Kuo FC, et al. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature. 1994;371(6494):221-226.
11. Papathanasiou P, Goodnow CC. Connecting mammalian genome with phenome by ENU mouse mutagenesis: gene combinations specifying the immune system. Annu Rev Genet. 2005;39:241-262.
12. Madhani HD, Styles CA, Fink GR. MAP kinases with distinct inhibitory functions impart signaling specificity during yeast differentiation. Cell. 1997;91(5):673-684.
13. Knight CG, Zitzmann N, Prabhakar S, et al. Unraveling adaptive evolution: how a single point mutation affects the protein coregulation network. Nat Genet. 2006;38(9):1015-1022.
14. Papathanasiou P, Perkins AC, Cobb BS, et al. Widespread failure of hematolymphoid differentiation caused by a recessive niche-filling allele of the Ikaros transcription factor. Immunity. 2003;19(1):131-144.
15. Tucker E, O'Donnell K, Fuchsberger M, et al. A novel mutation in the Nfkb2 gene generates an NF-kappa B2 "super repressor." J Immunol. 2007;179(11):7514-7522.
16. Masuya H, Nishida K, Furuichi T, et al. A novel dominant-negative mutation in Gdf5 generated by ENU mutagenesis impairs joint formation and causes osteoarthritis in mice. Hum Mol Genet. 2007;16(19):2366-2375.
17. Papathanasiou P, Attema JL, Karsunky H, et al. Self-renewal of the long-term reconstituting subset of hematopoietic stem cells is regulated by Ikaros. Stem Cells. 2009;27(12):3082-3092.
18. de Jong JL, Zon LI. Use of the zebrafish system to study primitive and definitive hematopoiesis. Annu Rev Genet. 2005;39:481-501.
19. Wingert RA, Brownlie A, Galloway JL, et al. The chianti zebrafish mutant provides a model for erythroid-specific disruption of transferrin receptor 1. Development. 2004;131(24):6225-6235.
20. Shaw GC, Cope JJ, Li L, et al. Mitoferrin is essential for erythroid iron assimilation. Nature. 2006;440(7080):96-100.
21. Ransom DG, Bahary N, Niss K, et al. The zebrafish moonshine gene encodes transcriptional intermediary factor 1gamma, an essential regulator of hematopoiesis. PLoS Biol. 2004;2(8):E237.
22. Carpinelli MR, Hilton DJ, Metcalf D, et al. Suppressor screen in Mpl-/- mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling. Proc Natl Acad Sci USA. 2004;101(17):6553-6558.
23. Sandberg ML, Sutton SE, Pletcher MT, et al. c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation. DevCell. 2005;8(2):153-166.
24. Anderson KV. Finding the genes that direct mammalian development: ENU mutagenesis in the mouse. Trends Genet. 2000;16(3):99-102.
25. Herron BJ, Lu W, Rao C, et al. Efficient generation and mapping of recessive developmental mutations using ENU mutagenesis. Nat Genet. 2002;30(2):185-189.
26. Papathanasiou P, Attema JL, Karsunky H. Xu J. Smale ST. Weissman IL. Evaluation of the longterm reconstituting subset of hematopoietic stem cells with CD150. Stem Cells. 2009;27(10):2498-2508.
27. Kim I, He S, Yilmaz OH. Kiel MJ. Morrison SJ. Enhanced purification of fetal liver hematopoietic stem cells using SLAM family receptors. Blood. 2006;108(2):737-744.
28. Traver D, Miyamoto T, Christensen J. Iwasaki-Arai J. Akashi K. Weissman IL. Fetal liver myelopoiesis occurs through distinct. prospectively isolatable progenitor subsets. Blood. 2001;98(3):627-635.
29. 2+ common lymphoid progenitors possess equivalent differentiation potential for the B and T lineages. Blood. 2008;111(12):5562-5570.
30. Perkins AC, Sharpe AH, Orkin SH. Lethal betathalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF Nature. 1995;375(6529):318-322.
31. Kieran MW, Perkins AC, Orkin SH. Zon LI. Thrombopoietin rescues in vitro erythroid colony formation from mouse embryos lacking the erythropoietin receptor. Proc Natl Acad Sci U S A. 1996;93(17):9126-9131.
32. Peters LL, Cheever EM, Ellis HR, et al. Largescale, high-throughput screening for coagulation and hematologic phenotypes in mice. Physiol Genomics. 2002;11(3):185-193.
33. Mandillo S, Tucci V, Holter SM, et al. Reliability, robustness, and reproducibility in mouse behavioral phenotyping: a cross-laboratory study. Physiol Genomics. 2008;34(3):243-255.
34. Spangrude GJ, Brooks DM. Mouse strain variability in the expression of the hematopoietic stem cell antigen Ly-6A/E by bone marrow cells. Blood. 1993;82(11):3327-3332.
35. de Haan G, Nijhof W, Van Zant G. Mouse straindependent changes in frequency and proliferation of hematopoietic stem cells during aging: correlation between lifespan and cycling activity. Blood. 1997;89(5):1543-1550.
36. Morrison SJ, Qian D, Jerabek L, et al. Agenetic determinant that specifically regulates the frequency of hematopoietic stem cells. J Immunol. 2002;168(2):635-642.
37. Beck JA, Lloyd S, Hafezparast M, et al. Genealogies of mouse inbred strains. Nat Genet. 2000;24(1):23-25.
38. Petkov PM, Ding Y, Cassell MA, et al. An efficient SNP system for mouse genome scanning and elucidating strain relationships. Genome Res. 2004;14(9):1806-1811.
39. Georgel P, Du X, Hoebe K. Beutler B. ENU mutagenesis in mice. Methods Mol Biol. 2008;415:1-16.
40. Cook MC, Vinuesa CG, Goodnow CC. ENU-mutagenesis: insight into immune function and pathology. CurrOpin Immunol. 2006;18(5):627-633.
41. Kina T, Ikuta K, Takayama E, et al. The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin Aand specifically marks the late stages of murine erythroid lineage. Br J Haematol. 2000;109(2):280-287.
42. Ramsay RG, Gonda TJ. MYB function in normal and cancer cells. Nat Rev Cancer. 2008;8(7):523-534.
43. Kauppi M, Murphy JM, de Graaf CA, et al. Point mutation in the gene encoding p300 suppresses thrombocytopenia in Mpl-/- mice. Blood. 2008;112(8):3148-3153.
44. Tefferi A. Myelofibrosis with myeloid metaplasia. N EnglJ Med. 2000;342(17):1255-1265.
45. Levine RL, Wadleigh M, Cools J, et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell. 2005;7(4):387-397.
46. Schnittger S, Bacher U, Haferlach C, et al. Characterization of 35 new cases with four different MPLW515 mutations and essential thrombocytosis or primary myelofibrosis. Haematologica. 2009;94(1):141-144.
47. Gnirke A, Melnikov A, Maguire J, et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol. 2009;27(2):182-189.